Vascular endothelial cells, macrophages, and a portion of tumor-infiltrating lymphocytes were positive for SLFN11 (16); therefore, we carefully excluded these cells from counting to properly assess SLFN11 positivity in tumor cells. Here, SLFN11 is linked to neoplasm.